← Leaderboards
Elena M Barbu
Synthetic Genomics Vaccines, Inc.
$988,283
Attributed
$988,283
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $417.9K · FY2017–19$500K$375K$250K$125K$0
'17
'18
'19
Funding mix
By agency
NIH$988,283 · 2
By mechanism
R33$798,757 · 1
R21$189,526 · 1
Top collaborators
No co-investigators on record.
Most similar at Synthetic Genomics Vaccines, Inc.
Same institution · by research overlap
- Bolyn Hubby$198,106
Others in their field
Other Emerging Leaders on “Genetic Engineering”
- Yunda Huang · Fred Hutchinson Cancer Center$52,003,716
- Sonia Minikel Vallabh · Broad Institute, Inc.$16,658,654
- Gary Fanger · Rise Therapeutics, Llc$12,490,386
- Benjamin E Deverman · Broad Institute, Inc.$11,628,265
- Jacqueline K White · Jackson Laboratory$11,525,170
- Afonso C Silva · University Of Pittsburgh At Pittsburgh$11,052,001
Research focus
Genetic EngineeringInfectious AgentClinical DevelopmentFederal GovernmentHost ResistanceInfectionCellsCharacteristicsClinical PracticeEngineeringGenomeAlternative TherapiesAntibiotic TherapyImmunityAntimicrobialAttentionBacteriaCessation Of LifeAnti-Bacterial AgentsBacteriophagesBaseAntibiotic ResistanceAntibioticsIn Vitro
Grant awards (3)
Towards the Development of Engineered Phage Therapeutics against MDR Pathogens$380,862
R33 · FY2019 · AI · contact PI
Towards the Development of Engineered Phage Therapeutics against MDR Pathogens$417,895
R33 · FY2018 · AI · contact PI
Towards the Development of Engineered Phage Therapeutics against MDR Pathogens$189,526
R21 · FY2017 · AI · contact PI